Please assess the completion status of the following clinical trial:

Trial Title: Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* You must be 18 to 65 years old.~* You must have a diagnosis of bipolar I disorder and must be experiencing a manic or mixed (symptoms of mania and depression occurring together) episode.~* You must be able to visit the doctor's office as scheduled for 15 weeks.~* All female patients must test negative for pregnancy and, if of childbearing potential, must be using a medically accepted means of contraception.~Exclusion Criteria:~* You have rapid cycling bipolar disorder, or are having hallucinations or delusions, or are feeling suicidal.~* You are pregnant or breastfeeding~* You have a history of: inadequately controlled diabetes; heart disease; narrow angle glaucoma; low white blood cell or platelet count; have a positive test result for human immunodeficiency virus (HIV+); or any other serious, unstable illnesses as judged by the study physician.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).